spacer
spacer

PDBsum entry 4x6h

Go to PDB code: 
protein ligands links
Hydrolase PDB id
4x6h

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chain
215 a.a.
Ligands
3XT-I37
SO4 ×6
Waters ×290
PDB id:
4x6h
Name: Hydrolase
Title: Development of n-(functionalized benzoyl)-homocycloleucyl- glycinonitriles as potent cathepsin k inhibitors.
Structure: Cathepsin k. Chain: a. Fragment: unp residues 115-329. Synonym: cathepsin o,cathepsin o2,cathepsin x. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: ctsk, ctso, ctso2. Expressed in: komagataella pastoris gs115. Expression_system_taxid: 644223
Resolution:
1.00Å     R-factor:   0.155     R-free:   0.166
Authors: J.Borisek,B.Mohar,M.Vizovisek,P.Sosnowski,D.Turk,B.Turk,M.Novic
Key ref: J.Borišek et al. (2015). Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors. J Med Chem, 58, 6928-6937. PubMed id: 26280490 DOI: 10.1021/acs.jmedchem.5b00746
Date:
08-Dec-14     Release date:   23-Sep-15    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P43235  (CATK_HUMAN) -  Cathepsin K from Homo sapiens
Seq:
Struc:
329 a.a.
215 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class: E.C.3.4.22.38  - cathepsin K.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Broad proteolytic activity. With small-molecule substrates and inhibitors, the major determinant of specificity is P2, which is preferably Leu, Met > Phe, and not Arg.

 

 
DOI no: 10.1021/acs.jmedchem.5b00746 J Med Chem 58:6928-6937 (2015)
PubMed id: 26280490  
 
 
Development of N-(Functionalized benzoyl)-homocycloleucyl-glycinonitriles as Potent Cathepsin K Inhibitors.
J.Borišek, M.Vizovišek, P.Sosnowski, B.Turk, D.Turk, B.Mohar, M.Novič.
 
  ABSTRACT  
 
Cathepsin K is a major drug target for osteoporosis and related-bone disorders. Using a combination of virtual combinatorial chemistry, QSAR modeling, and molecular docking studies, a series of cathepsin K inhibitors based on N-(functionalized benzoyl)-homocycloleucyl-glycinonitrile scaffold was developed. In order to avoid previous problems of cathepsin K inhibitors associated with lysosomotropism of compounds with basic character that resulted in off-target effects, a weakly- to nonbasic moiety was incorporated into the P3 position. Compounds 5, 6, and 9 were highly selective for cathepsin K when compared with cathepsins L and S, with the Ki values in the 10-30 nM range. The kinetic studies revealed that the new compounds exhibited reversible tight binding to cathepsin K, while the X-ray structural studies showed covalent and noncovalent binding between the nitrile group and the catalytic cysteine (Cys25) site.
 

 

spacer

spacer